Cue Biopharma, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLEICHROEDER LP | 02/14/2025 | 5.00 M | $5.45 M | 0.00% | 9.75% |
VANGUARD GROUP INC | 02/11/2025 | 2.06 M | $2.24 M | 1.22% | 4.01% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 638,952 | $696,458 | 11.91% | 1.25% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 631,281 | $688,251 | 24.07% | 1.23% |
ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | 01/27/2025 | 478,500 | $521,565 | 0.00% | 0.93% |
SIGMA PLANNING CORP | 02/03/2025 | 447,175 | $487,421 | 11.42% | 0.87% |
GOOD LIFE ADVISORS, LLC | 02/03/2025 | 400,000 | $436,000 | 0.00% | 0.78% |
ADVISORY RESEARCH INC | 02/13/2025 | 257,225 | $280,375 | 0.00% | 0.50% |
STIFEL FINANCIAL CORP | 02/13/2025 | 211,361 | $230,383 | 8.82% | 0.41% |
STATE STREET CORP | 02/14/2025 | 189,753 | $206,831 | 7.17% | 0.37% |
GSA CAPITAL PARTNERS LLP | 02/07/2025 | 149,798 | $163,000 | -48.64% | 0.29% |
HIGHTOWER ADVISORS, LLC | 02/07/2025 | 128,284 | $139,830 | 54.03% | 0.25% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 69,295 | $75,532 | -80.70% | 0.14% |
JANE STREET GROUP, LLC | 02/14/2025 | 63,767 | $69,506 | 145.87% | 0.12% |
UBS GROUP AG | 02/14/2025 | 58,314 | $63,562 | -21.38% | 0.11% |
HRT FINANCIAL LP | 02/14/2025 | 49,055 | $53,000 | 100.00% | 0.10% |
XTX TOPCO LTD | 02/13/2025 | 46,973 | $51,201 | 69.79% | 0.09% |
LPL FINANCIAL LLC | 02/11/2025 | 42,929 | $46,793 | 139.49% | 0.08% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 34,525 | $37,632 | 85.99% | 0.07% |
TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC | 02/13/2025 | 33,102 | $36,081 | 100.00% | 0.06% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 27,764 | $30,263 | 15.21% | 0.05% |
NAVALIGN, LLC | 02/18/2025 | 25,000 | $27,250 | 100.00% | 0.05% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 20,077 | $21,884 | 0.00% | 0.04% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/14/2025 | 20,000 | $22,000 | 0.00% | 0.04% |
SQUAREPOINT OPS LLC | 02/14/2025 | 19,680 | $21,451 | 100.00% | 0.04% |
VIRTU FINANCIAL LLC | 02/11/2025 | 16,829 | $18,000 | 100.00% | 0.03% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 13,258 | $14,451 | 100.00% | 0.03% |
SEACREST WEALTH MANAGEMENT, LLC | 01/14/2025 | 13,000 | $14,170 | 0.00% | 0.03% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 11,200 | $12,208 | 100.00% | 0.02% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 10,542 | $11,491 | 46.07% | 0.02% |
BEACON POINTE ADVISORS, LLC | 02/14/2025 | 10,000 | $10,900 | 0.00% | 0.02% |
SIMPLEX TRADING, LLC | 02/11/2025 | 6,908 | $7,000 | 70.32% | 0.01% |
BARCLAYS PLC | 02/13/2025 | 6,029 | $7,000 | 0.00% | 0.01% |
GLEASON GROUP, INC. | 01/13/2025 | 6,000 | $6,540 | 0.00% | 0.01% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 3,661 | $3,990 | 100.00% | 0.01% |
NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 01/28/2025 | 3,000 | $3,270 | 0.00% | 0.01% |
NEWEDGE ADVISORS, LLC | 02/13/2025 | 2,550 | $2,780 | 0.00% | 0.01% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/11/2025 | 2,500 | $2,725 | 0.00% | 0.00% |
GOLDEN STATE WEALTH MANAGEMENT, LLC | 01/28/2025 | 2,000 | $2,180 | 100.00% | 0.00% |
LARSON FINANCIAL GROUP LLC | 02/07/2025 | 1,400 | $1,526 | 0.00% | 0.00% |
JPMORGAN CHASE & CO | 02/12/2025 | 1,062 | $1,157 | 17.48% | 0.00% |
PHYSICIAN WEALTH ADVISORS, INC. | 02/12/2025 | 1,006 | $1,097 | 100.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 854 | $931 | 6.62% | 0.00% |
MAI CAPITAL MANAGEMENT | 02/14/2025 | 350 | $382 | 100.00% | 0.00% |
SUNBELT SECURITIES, INC. | 02/18/2025 | 237 | $242 | 0.00% | 0.00% |
ARMSTRONG ADVISORY GROUP, INC | 01/14/2025 | 120 | $131 | 0.00% | 0.00% |
IFP ADVISORS, INC | 02/04/2025 | 100 | $109 | 0.00% | 0.00% |
FMR LLC | 02/13/2025 | 96 | $105 | -66.32% | 0.00% |
POINT72 (DIFC) LTD | 02/14/2025 | 66 | $72 | 13.79% | 0.00% |
01/29/2025 | 62 | $68 | 100.00% | 0.00% |
Cue Biopharma, Inc. institutional Ownership - FAQ's
During the previous two years, 73 institutional investors and hedge funds held shares of Cue Biopharma, Inc.. The most heavily invested institutionals were:
Bleichroeder LP: 5 M
VANGUARD GROUP INC: 2.06 M
BlackRock Funding, Inc. /DE: 638,952
GEODE CAPITAL MANAGEMENT, LLC: 631,281
Robertson Stephens Wealth Management, LLC: 478,500
Sigma Planning Corp: 447,175
22.95% of Cue Biopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 12.53 M shares in the last 24 months. This purchase volume represents approximately $21.93 M in transactions.